Last updated on April 2020

A Study of Intravenous Perampanel in Japanese Participants With Epilepsy


Brief description of study

The purpose of the study is to evaluate the safety and tolerability of perampanel administered as a 30-minute intravenous infusion after switching from oral tablets (8 to 12 milligrams per day [mg/day]) as an adjunctive therapy in participants with epilepsy with partial onset seizures (including secondarily generalized seizures) or primary generalized tonic-clonic seizures.

Clinical Study Identifier: NCT03754582

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.